These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31807895)

  • 1. Mitochondrial Control of Fungal Cell Walls: Models and Relevance in Fungal Pathogens.
    Koch B; Traven A
    Curr Top Microbiol Immunol; 2020; 425():277-296. PubMed ID: 31807895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products targeting the synthesis of β(1,3)-D-glucan and chitin of the fungal cell wall. Existing drugs and recent findings.
    Curto MÁ; Butassi E; Ribas JC; Svetaz LA; Cortés JCG
    Phytomedicine; 2021 Jul; 88():153556. PubMed ID: 33958276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Wall-Modifying Antifungal Drugs.
    Perlin DS
    Curr Top Microbiol Immunol; 2020; 425():255-275. PubMed ID: 31875267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multitude of targets for the immune system and drug therapy in the fungal cell wall.
    Nimrichter L; Rodrigues ML; Rodrigues EG; Travassos LR
    Microbes Infect; 2005 Apr; 7(4):789-98. PubMed ID: 15823515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echinocandins: The Expanding Antifungal Armamentarium.
    Aguilar-Zapata D; Petraitiene R; Petraitis V
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Our pursuit for effective antifungal agents targeting fungal cell wall components: where are we?
    Ibe C; Oladele RO; Alamir O
    Int J Antimicrob Agents; 2022 Jan; 59(1):106477. PubMed ID: 34798234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell wall integrity is linked to mitochondria and phospholipid homeostasis in Candida albicans through the activity of the post-transcriptional regulator Ccr4-Pop2.
    Dagley MJ; Gentle IE; Beilharz TH; Pettolino FA; Djordjevic JT; Lo TL; Uwamahoro N; Rupasinghe T; Tull DL; McConville M; Beaurepaire C; Nantel A; Lithgow T; Mitchell AP; Traven A
    Mol Microbiol; 2011 Feb; 79(4):968-89. PubMed ID: 21299651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.
    Hasim S; Coleman JJ
    Future Med Chem; 2019 Apr; 11(8):869-883. PubMed ID: 30994368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy.
    Shingu-Vazquez M; Traven A
    Eukaryot Cell; 2011 Nov; 10(11):1376-83. PubMed ID: 21926328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echinocandins: production and applications.
    Emri T; Majoros L; Tóth V; Pócsi I
    Appl Microbiol Biotechnol; 2013 Apr; 97(8):3267-84. PubMed ID: 23463246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspofungin: an echinocandin antifungal agent.
    Stone EA; Fung HB; Kirschenbaum HL
    Clin Ther; 2002 Mar; 24(3):351-77; discussion 329. PubMed ID: 11952021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review.
    Sun HY; Singh N
    Int J Antimicrob Agents; 2010 Mar; 35(3):211-8. PubMed ID: 20036518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances].
    Cuenca-Estrella M
    Rev Esp Quimioter; 2010 Dec; 23(4):169-76. PubMed ID: 21191554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes.
    Song JC; Stevens DA
    Crit Rev Microbiol; 2016 Sep; 42(5):813-46. PubMed ID: 26369708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside.
    Cuenca-Estrella M
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():54-9. PubMed ID: 24372680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fungal Cell Wall: Structure, Biosynthesis, and Function.
    Gow NAR; Latge JP; Munro CA
    Microbiol Spectr; 2017 May; 5(3):. PubMed ID: 28513415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
    Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
    Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fungal cell wall as a target for the development of new antifungal therapies.
    Cortés JCG; Curto MÁ; Carvalho VSD; Pérez P; Ribas JC
    Biotechnol Adv; 2019 Nov; 37(6):107352. PubMed ID: 30797093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echinocandin resistance in human pathogenic fungi.
    Munro CA
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):115-6. PubMed ID: 22339184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.